SENSI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 1.064
AS - Asia 483
EU - Europa 452
SA - Sud America 72
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 34
Totale 2.146
Nazione #
US - Stati Uniti d'America 1.034
SG - Singapore 186
DE - Germania 116
CN - Cina 110
IT - Italia 98
HK - Hong Kong 70
SE - Svezia 54
BR - Brasile 52
GB - Regno Unito 45
VN - Vietnam 45
AT - Austria 39
BG - Bulgaria 31
CA - Canada 22
FR - Francia 21
RU - Federazione Russa 15
CI - Costa d'Avorio 14
FI - Finlandia 14
TR - Turchia 14
IN - India 12
SN - Senegal 12
AR - Argentina 9
BD - Bangladesh 7
ZA - Sudafrica 7
IQ - Iraq 6
PL - Polonia 6
ES - Italia 5
JP - Giappone 5
KR - Corea 4
MX - Messico 4
SA - Arabia Saudita 4
CO - Colombia 3
NG - Nigeria 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
EC - Ecuador 2
EE - Estonia 2
IL - Israele 2
JM - Giamaica 2
PH - Filippine 2
PT - Portogallo 2
VE - Venezuela 2
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
ID - Indonesia 1
IE - Irlanda 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
NL - Olanda 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
RO - Romania 1
TW - Taiwan 1
UY - Uruguay 1
Totale 2.112
Città #
Ashburn 130
Singapore 88
Chandler 87
Fairfield 76
Hong Kong 67
Santa Clara 64
Woodbridge 63
San Jose 62
Ann Arbor 49
Houston 46
Dallas 41
Seattle 38
Vienna 37
Sofia 31
Cambridge 30
Wilmington 28
Beijing 27
Los Angeles 25
Shanghai 25
New York 22
Council Bluffs 20
Serra 17
Abidjan 14
Boardman 14
Pisa 14
Princeton 14
Bremen 13
Munich 13
Dakar 12
Florence 12
Lawrence 12
Dong Ket 11
Medford 11
Dearborn 10
Istanbul 10
Lauterbourg 10
Ottawa 10
Hanoi 9
London 9
Buffalo 8
Des Moines 8
Lancaster 8
Düsseldorf 6
Ho Chi Minh City 6
Montreal 6
Frankfurt am Main 5
Lucca 5
Nanjing 5
Tokyo 5
Turku 5
Warsaw 5
Baghdad 4
Lappeenranta 4
Ogden 4
Shenzhen 4
Signa 4
São Paulo 4
Toronto 4
Bologna 3
Brent 3
Chicago 3
Daejeon 3
Denver 3
Guangzhou 3
Hebei 3
Johannesburg 3
Lagos 3
Pescara 3
Phoenix 3
Poplar 3
Rio de Janeiro 3
San Francisco 3
Atlanta 2
Brooklyn 2
Campo Grande 2
Capannori 2
Chennai 2
Colombo 2
Da Nang 2
Durban 2
Grand Rapids 2
Guarulhos 2
Guayaquil 2
Itajubá 2
Marseille 2
Milan 2
Nuremberg 2
Positano 2
Pune 2
Riyadh 2
San Diego 2
Santo André 2
Seacroft 2
Tashkent 2
Tianjin 2
Abha 1
Addlestone 1
Alcântaras 1
Algiers 1
Almaty 1
Totale 1.464
Nome #
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 252
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer 226
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 203
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 188
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial 186
Clinical Impact of Pretreatment EGFR T790M Mutation in Lung Adenocarcinoma Patients 176
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. 171
Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer 163
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer 146
Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series 142
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months. 140
null 78
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma 75
Totale 2.146
Categoria #
all - tutte 6.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 0 0 2 24 25 1 7 7 9 4 40
2022/2023275 23 49 19 35 34 28 0 17 51 2 15 2
2023/2024103 9 7 16 4 10 20 8 7 2 3 5 12
2024/2025439 2 13 3 23 49 49 26 13 54 55 53 99
2025/2026521 46 34 48 56 79 31 75 36 34 48 14 20
2026/202776 13 27 36 0 0 0 0 0 0 0 0 0
Totale 2.146